Global enzymes market to reach $7.2 billion in 2020: Report

While demand for enzymes used in research, biotech and diagnostics is like to post strong gains, the fastest growth will be seen for biocatalysts, particularly used in pharma, says Freedonia report

Research lab image via Shutterstock.
<a href="http://www.shutterstock.co.in/pic-89254516/stock-photo-scientist-working-at-the-laboratory.html?src=ORKKA0MMUSHlJ3KzTkYwPQ-1-43" target="_blank">Research lab</a> image via Shutterstock.
BS B2B Bureau Cleveland, Ohio (USA)
Last Updated : Jun 23 2016 | 8:52 PM IST
The global enzymes market is expected to grow on average 4.6 percent through 2020 to $7.2 billion from $5.78 billion in 2015, according to Freedonia Group’s new report. This market includes enzymes used in industrial applications (food and beverages, cleaning products, biofuel production, animal feed, and other markets) and specialty applications (research and biotechnology, diagnostics, and biocatalysts). Food and beverages will remain the largest market for enzymes, with gains driven by increasing consumption of products containing enzymes in developing regions.
 
Most industrial markets in developed countries are mature, with intensive competition among enzyme manufacturers. In order to maintain and expand market share in these countries, manufacturers are continually improving their enzymes to offer efficient performance at lower temperatures and under extreme pH conditions, lower costs via reduced energy and water usage, and produce higher quality end products with larger amounts of marketable co-products. “This continued introduction of new enzyme formulations will sustain growth in demand in mature industrial markets, including the food and beverage, cleaning product, and textile and leather markets,” stated the Freedonia report.
 
In contrast to industrial markets, the specialty enzyme markets are expanding at a strong pace globally. “While demand for enzymes used in research and biotechnology and in diagnostics is forecast to post strong gains, the fastest growth will be seen for biocatalysts, particularly those used in the production of pharmaceuticals,” observed Christine O’Keefe, analyst, Freedonia Group.
 
Rising healthcare costs in developed countries have led providers to adopt a ‘personalised’ medicine approach, in which healthcare is tailored to the individual based on clinical profile, genetic background, and personal preferences. This approach to medicine requires the increased use of diagnostic testing as well as genomic sequencing, helping to drive strong demand for diagnostic enzymes. In developing countries, the number of diagnostic tests will increase as the number of insured individuals rises, further supporting growth in demand for the enzymes used in diagnostic testing.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jun 23 2016 | 8:49 PM IST

Next Story